期刊文献+

PNKP沉默对骨肉瘤放疗的增敏作用 被引量:1

PNKP silencing increases radiosensitivity of osteosarcoma cells in vitro
下载PDF
导出
摘要 目的研究多聚核苷酸激酶/磷酸酶(polynucleotide kinase/phosphatase,PNKP)在放疗诱导的细胞DNA损伤、细胞凋亡、细胞增殖和细胞周期中的调节作用。方法将U2OS细胞系分为3组:骨肉瘤细胞对照组、阴性si RNA转染组(si C)和PNKP si RNA转染组(si PNKP)。Western blot检测0、1、2、4、6、8 Gy 6个剂量水平γ-射线照射后U2OS细胞中PNKP的变化,CCK-8分析不同剂量γ-射线照射后细胞的存活率,彗星实验检测辐射后骨肉瘤细胞DNA的损伤,MTT法检测辐射后细胞增殖情况,流式细胞仪分析辐射后细胞凋亡、线粒体膜电位和细胞周期的变化。结果 4 Gy剂量的γ-射线可以显著降低骨肉瘤细胞U2OS中PNKP的表达(55.17%,P<0.01)和细胞的存活能力(与对照组相比下降50.16%,P<0.01)。与单独辐射组(si C+IR)对比,PNKP沉默可以抑制辐照后细胞的生长(抑制率增加到129.61%,P<0.01),增加DNA的损伤(DNA迁移量增加58.94%,P<0.01),使细胞周期停滞在S期,促进细胞凋亡以及降低线粒体膜电位水平。结论 PNKP沉默可以增加骨肉瘤细胞放射治疗的敏感性。 Objective To investigate the impact of polynucleotide kinase/phosphatase (PNKP) silencing on radiation-induced DNA damage, apoptosis, cell proliferation and cell cycle in osteosarcoma cells. Methods U2OS cells were divided into control (Ctrl) group, negative siRNA (siC) group and siPNKP group. After different doses (0, 1, 2, 4, 6 and 8 Gy) of γ-ray irradiation, the changes of PNKP level and cell survival rate were determined using Western blotting and CCK-8 assay. After irradiation at the best dose, DNA damage and cell proliferation were evaluated by Comet assay and MTT assay, respectively. Apoptosis, mitochondrial membrane potential and cell cycle were analyzed by flow cytometry. Results Irradiation of 4-Gy ~/-rays to osteosarcoma cells significantly reduced PNKP expression ( 55. 17% , P 〈 0.01 ) and cell viability (50. 16% , P 〈 0.01 ) compared with the Ctd group. PNKP silencing inhibited the cell growth (inhibitory rate reached to 129.61% , P 〈 0.01 ) and increased DNA damage ( DNA migration amount increased by 58.94% , P 〈 0.01 ) after irradiation. It also could arrest the cell cycle in S phase, accelerate apoptosis and reduce mitochondrial membrane potential as compared with the siCtrl + IR group. Conclusion PNKP silencing increases osteosarcoma cell sensitivity to radiation therapy.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2016年第4期390-395,共6页 Journal of Third Military Medical University
基金 甘肃省科技厅自然科学研究基金计划(1208RJZA272) 甘肃省科技厅创新研究群体计划(2013GS10047)~~
关键词 多聚核苷酸激酶/磷酸酶 骨肉瘤 放疗敏感性 polynucleotide kinase/phosphatase osteosarcoma radiosensitivity
  • 相关文献

参考文献15

  • 1Ando K, Heymann M F, Stresing V, et al. Current therapeutic strategies and novel approaches in osteosarcoma. Cancers (Basel), 2013, 5(2): 591-616. DOI:10.3390/cancers5020591.
  • 2Gao R, Liu Y, Silva-Fernandes A, et al. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3. PLoS Genet, 2015, 11(1): e1004834. DOI:10.1371/journal.pgen.1004834.
  • 3Xu Y, Her C. Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy. Biomolecules, 2015, 5(3): 1652-1670. DOI:10.3390/biom5031652.
  • 4李梦侠,王东,向德兵,张云嵩,杨宇馨,龙在云.电离辐射诱导骨肉瘤细胞DNA损伤修复蛋白APE1线粒体定位研究[J].第三军医大学学报,2007,29(15):1458-1461. 被引量:3
  • 5王东,张沁宏,仲召阳,李增鹏,Mark R Kelley.骨肉瘤DNA损伤修复相关基因表达与预后的关系[J].第三军医大学学报,2005,27(13):1370-1373. 被引量:5
  • 6Schwarz R, Bruland O, Cassoni A, et al. The role of radiotherapy in oseosarcoma. Cancer Treat Res, 2009, 152: 147-164. DOI:10.1007/978-1-4419-0284-9_7.
  • 7Blattmann C, Oertel S, Schulz-Ertner D, et al. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. BMC Cancer, 2010, 10: 96. DOI:10.1186/1471-2407-10-96.
  • 8Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol, 2002, 20(22): 4466-4471.
  • 9逄璐,孙广毅,张志慧,任自敬,曾赵军.PNKP在DNA损伤修复中的作用[J].生命的化学,2014,34(6):787-792. 被引量:1
  • 10Rasouli-Nia A, Karimi-Busheri F, Weinfeld M. Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents. P Proc Natl Acad Sci U S A, 2004, 101(18): 6905-6910. DOI:10.1073/pnas.0400099101.

二级参考文献51

  • 1卿毅,王东,李增鹏,何怡,张沁宏.人骨肉瘤细胞HOS锎-252中子放射敏感性的研究[J].第三军医大学学报,2006,28(2):117-120. 被引量:5
  • 2Ragland B D, Bell W C, Lopez R R, et al. Cytogenetics and molecular biology of osteosarcoma[J]. Lab Invest, 2002, 82(4): 365 - 373.
  • 3Dong Wang, Meihua Luo, Mark Kelley. Human apurinic endonuclease 1 (APE1) expressiong and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition[J]. Mol Cancer Ther, 2004, 3(6): 679-686.
  • 4Mintz M B, Sowers R, Brown K M, et al. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma[ J]. Cancer Res, 2005,65(5): 1748- 1754.
  • 5Kim N K, Ahn J Y, Song J, et al. Expression of the DNA repair enzyne,N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors[J]. Anticancer Res, 2003, 23(2B): 1417 - 1423.
  • 6Kim N K, An H J, Kim H J, et al. Altered expression ofthe NDA repair protein, N-methylpurine-DNA glycosylase (MPG) in human gonads [ J].Anticancer Res, 2002, 22(2A): 793- 798.
  • 7Park S Y, Lam W, Cheng Y C. X-ray repair cross-complementing gene Iprotein plays an important role in camptothecin resistance[J]. Cancer Res,2002, 62(2): 459 - 465.
  • 8Evans A R, Limp-Foster M, Kelley M R. Going APE over ref-l[J]. Mutat Res, 2000, 461(2): 83- 108.
  • 9Puglisi F, Barbone F, Tell G, et al . Prognostic role of Ape/Ref-1 subcellar expression in stage Ⅰ -Ⅲ breast carcinomas[J]. Oncol Rep, 2002, 9(1): 11-17.
  • 10Esteller M, Herman J G. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer [J]. Oncogene, 2004, 23(1): 1-8.

共引文献6

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部